Skip to main content
All lobbying filings

MISSION ROLL CALL

Lobbying for MISSION ROLL CALL · Nonprofit organization serving veterans

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$30,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
South Carolina

Official filing document

 Government bodies contacted 3
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • Veterans Affairs, Dept of (VA)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 4
 Lobbying activity 4
Veterans

HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.

Budget/Appropriations

HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.

Health Issues

HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.

Medical/Disease Research/Clinical Labs

HR 740, Veterans' ACCESS Act. Direct outreach, policy discussions, and coordination regarding access to timely care and community care delivery. S 800, Precision Brain Health Research Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). S 862, HBOT Access Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 72, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 1136, TBI and PTSD Treatment Act. Education and advocacy on emerging treatment pathways, including non-traditional, evidence-building, and prevention-oriented approaches (Left of Clinical). HR 6993, BEACON Act. Direct engagement and coordination with congressional offices and partner organizations related to program structure and implementation pathways. VA funding and appropriations priorities. No specific legislation. Development of briefing materials, survey-informed insights, and engagement with congressional offices regarding VA funding levels, program prioritization, oversight, and cost-effective prevention strategies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem